Literature DB >> 6967349

Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases.

G Frizzera, J Rosai, L P Dehner, B D Spector, J H Kersey.   

Abstract

A histologic review was undertaken of 35 lymphoreticular disorders that developed in primary immuno-deficiency patients from the Immunodeficiency Cancer Registry. Twenty-one (60%) of the lesions were non-Hodgkin's lymphomas: these included eight B-immunoblastic sarcomas. Eight (23%) of the lesions were Hodgkin's disease, with a high frequency of lymphocytic depletion type in an unusually young age group. Three lesions (8.5%) represented abnormal proliferative processes, which could not be definitely categorized as either benign or malignant. There were only two acute lymphoblastic leukemias (6%). Differences were found between lymphomas arising in Wiskott-Aldrich syndrome and those occurring in ataxia-telangiectasia; this suggests that different pathogenetic mechanisms might operate in their development. The lymphomas in Wiskott-Aldrich syndrome were all of non-Hodgkin's type, predominantly B-immunoblastic sarcomas, and presented as localized extranodal infiltrates. The lymphomas in ataxia-telangiectasia were either Hodgkin's disease, mostly of lymphocytic depletion type, or non-Hodgkin's lymphomas of the histologic subtypes associated with 14q translocations.

Entities:  

Mesh:

Year:  1980        PMID: 6967349     DOI: 10.1002/1097-0142(19800815)46:4<692::aid-cncr2820460410>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Lymphoproliferative disorders in organ transplant recipients.

Authors:  Y Vanrenterghem
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

2.  Combined immunodeficiency preceding chronic lymphocytic leukemia.

Authors:  J W Lenders; B E de Pauw; M J Bogman; C Haanen
Journal:  Blut       Date:  1984-03

Review 3.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

4.  Diffuse large B cell lymphoma in wiskott-Aldrich syndrome: a case report and review of literature.

Authors:  Jayastu Senapati; Anup J Devasia; Sachin David; Marie Therese Manipadam; Sheila Nair; Giridhara R Jayandharan; Biju George
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-11       Impact factor: 0.900

5.  Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.

Authors:  H Ratech; R Hirschhorn; M A Greco
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Primary brain lymphomas in patients with a prior or concomitant malignancy.

Authors:  M Reni; A J Ferreri; M C Zoldan; E Villa
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

7.  Incidence of cancer in 98 patients with common varied immunodeficiency.

Authors:  C Cunningham-Rundles; F P Siegal; S Cunningham-Rundles; P Lieberman
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

Review 8.  Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.

Authors:  G Gaidano; C Pastore; C Lanza; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

9.  Promotional effects of azathioprine on peripheral B cell lymphomas in BALB/c mice induced by administration of 7,12-dimethylbenz[a]anthracene.

Authors:  K Fujiwara; T Yoshino; T Akagi; N Teramoto; K Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Lymphoproliferative disease in antibody deficiency: a multi-centre study.

Authors:  M M Gompels; E Hodges; R J Lock; B Angus; H White; A Larkin; H M Chapel; G P Spickett; S A Misbah; J L Smith
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.